Skip to main content

Publications

  1. Friedman J, Jamshidi P, Huang W  Cushing disease and unilateral primary aldosteronism confounded by a nonfunctioning contralateral adrenal incidentaloma.  JCEM Case Rep  2026 Jun;4(6):luag114. pii:luag114
  2. Iverson GL, Jamshidi P, Deep-Soboslay A, Hyde TM, Kleinman JE, Shepherd CE, Hazrati LN, Castellani RJ  Cortical subpial aging-related tau astrogliopathy in older adult men who participated in youth amateur American-style football.  J Neuropathol Exp Neurol  2026 May 20;. pii:nlag032
  3. Quiring ML, Edwards L, Bangen KJ, Ho EH, Carlsson CM, Galasko D, Weintraub S, Gershon R, Salmon DP  Effects of age and APOE ϵ4 genotype on the relationship between pulse pressure and executive function in older adults without Dementia.  J Int Neuropsychol Soc  2026 May 13;:1-10. doi:10.1017/S1355617726102008
  4. Hammers DB, Polsinelli A, Eloyan A, Taurone A, Thangarajah M, Foroud T, Gao S, Beckett L, La Joie R, Touroutoglou A  et al.  Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.  Alzheimers Dement (Amst)  2026;18:e70342. pii:e70342
  5. Hammers DB, Foster E, Eloyan A, Thangarajah M, Taurone A, Touroutoglou A, La Joie R, Beckett L, Gao S, Vemuri P  et al.  Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.  Alzheimers Dement  2026 May;22(5):e71492. pii:e71492
  6. Wang H, Walenski M, Litcofsky K, Mack JE, Mesulam MM, Thompson CK  Online comprehension of verbal time reference in primary progressive aphasia: Evidence from eyetracking.  J Neurolinguistics  2026 May;78. pii:101318
  7. Dutt S, Leichter D, Cobigo Y, Wolf A, Kornak J, Clark A, Russell LL, Bouzigues A, Cash DM, Bocchetta M  et al.  Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling.  Ann Neurol  2026 May;99(5):1315-1326. doi:10.1002/ana.78167
  8. Split M, Kunicki ZJ, Ross D, Keszycki R, Prieto S, Manoochehri M, De Vito AN, Appleby B, Hales CM, Onyike C  et al.  Factors influencing accelerated progression in behavioral variant frontotemporal dementia.  J Neurol  2026 Apr 30;273(5). pii:297
  9. Høilund-Carlsen PF, Alavi A, Andalib S, Castellani RJ, Costa T, de Girolamo G, Espay AJ, Neve RL, Perry G, Revheim ME  et al.  Serious side effects of Alzheimer's immunotherapy demand scrutiny.  Ageing Res Rev  2026 Apr 27;119:103151. doi:10.1016/j.arr.2026.103151
  10. Wirtshafter HS, Mehta MR, Solla SA, Disterhoft JF  Hippocampal conditioning code dominates and disrupts the place code.  bioRxiv  2026 Apr 20;. pii:2026.02.17.706430
  11. Barbieri E, Kawles AS, Los M, Behn J, Geula C, Gefen T, Weintraub S, Mesulam MM  Atrophy progression in frontotemporal lobar degeneration-TDP-C with primary progressive aphasia.  Brain  2026 Apr 07;149(4):1194-1207. doi:10.1093/brain/awaf369
  12. Chan CK, Glover CM, Parker M, Grill JD, Langbaum JB, Morhardt DJ, Okonkwo O, Farrar-Edwards D, Wang S  Outreach, Recruitment and Engagement Cores of NIA-designated Alzheimer's Disease Research Centers: Current strategies and future directions.  Alzheimers Dement  2026 Apr;22(4):e71238. pii:e71238
  13. De Coster W, Van den Broeck M, Baker M, Ghayal NB, Wynants S, Batzler A, Pottier C, Alidadiani S, Küçükali F, Jenkins GD  et al.  A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.  Nat Genet  2026 Apr;58(4):726-736. doi:10.1038/s41588-026-02537-7
  14. Disouky A, Sanborn MA, Sabitha KR, Mostafa MM, Ayala IA, Bennett DA, Lu Y, Zhou Y, Keene CD, Weintraub S  et al.  Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease.  Nature  2026 Apr;652(8112):1264-1273. doi:10.1038/s41586-026-10169-4
  15. Alvarez FR, Nayman EI, Chen YH, Chen QC, Jamshidi P, Dixit K, Tariq H  Polymorphic central nervous system (CNS) immune deficiency/dysregulation-associated lymphoproliferative disorders show a uniquely aggressive clinicopathologic profile compared to their extra-CNS counterparts.  Hum Pathol  2026 Apr;170:106051. doi:10.1016/j.humpath.2026.106051
  16. Smith HL, Duckett DJ, Mejia-Bautista M, Alshawa A, Jamshidi P, Castellani RJ, Lukas RV, Chandler JP, Jennings LJ, Santana-Santos L  et al.  IDH-wildtype astrocytoma with FH mutation, epigenetic similarity to IDH-mutant astrocytoma, and hypermethylation of CDKN2A arising in the brainstem.  J Neuropathol Exp Neurol  2026 Apr 01;85(4):398-401. doi:10.1093/jnen/nlaf086
  17. Sadleir KR, Gomez KP, Chandra S, Ley ML, Khatri AW, Guo J, Xue Y, Cepko CL, Vassar R  Neuronal overexpression of Nrf2 reduces dystrophic neurites in 5XFAD Alzheimer's disease model mice.  bioRxiv  2026 Mar 18;. pii:2026.03.16.711596
  18. Song R, Dapash M, Jamshidi P, Gondi V, Lukas RV, Khan OH  Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy.  J Neurooncol  2026 Mar 17;177(2). pii:62
  19. Gutstein DB, Iorga M, Stocks J, Gill N, Sleeman J, Gefen TD, Los M, Nelson C, Geula C, Weintraub S  et al.  Identifying neuropathologic disease in primary progressive aphasia using narrative speech.  Alzheimers Dement  2026 Mar;22(3):e71294. pii:e71294
  20. George E, Braun M, Vassar R, Fox CK, Siegel DH, Mathes E, Frieden IJ, Hess CP, ,   Multi-center study of long-term evolution of neuroimaging findings in PHACE syndrome.  Eur J Paediatr Neurol  2026 Mar;61:1-7. doi:10.1016/j.ejpn.2026.02.004
  21. Salvo MA, Cuddy LK, Prokopenko D, Watkins E, Tanzi RE, Vassar R  Alzheimer's disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II.  J Biol Chem  2026 Mar;302(3):111171. pii:111171
  22. Kawles A, Nelson C, Ayala I, Barbieri E, Castellani R, Geula C, Gefen T, Mesulam MM  Anatomical Progression of Neuropathology in FTLD-TDP Type C and Linkage to Annexin A11.  Ann Neurol  2026 Mar;99(3):639-655. doi:10.1002/ana.78095
  23. Coty-Fattal Z, Smith H, McCord M, Mejia-Bautista M, Dittman D, Primdahl D, Conway K, Becker N, Ahrendsen JT, Santana-Santos L  et al.  Rapid assessment of MGMT promoter methylation status by droplet digital polymerase chain reaction on intraoperative smear preparation: A proof-of-concept study.  J Neuropathol Exp Neurol  2026 Mar 01;85(3):280-284. doi:10.1093/jnen/nlaf122
  24. Bertholim-Nasciben L, Wang L, Xu W, Ramirez A, Moura S, Lu L, Liu X, Rajabli F, Celis K, Gearing M  et al.  Enhanced Hi-C Capture Analysis reveals complex regulatory architecture at the PICALM_EED locus for Alzheimer's disease.  bioRxiv  2026 Feb 17;. pii:2026.02.14.705927
  25. Youngblood MW, Tripathi S, Najem H, Congivaram H, Gomez M, Sears TK, Hurley L, Billingham LK, Silvers C, Wang W  et al.  STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.  Nat Commun  2026 Feb 12;17(1). pii:2685
  26. Rao NR, Santiago-Marrero I, DeGulis O, Nomura T, Goyal K, Lee S, Hark TJ, Dynes JC, Dexter EX, Dulewicz M  et al.  Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.  Sci Transl Med  2026 Feb 11;18(836):eadp3984. doi:10.1126/scitranslmed.adp3984
  27. Macomber A, Zouridakis A, Lubbat V, Minogue G, Kawles A, Keszycki R, Nelson C, Gill N, Gutstein D, Castellani R  et al.  Vulnerability of anterior cingulate Von Economo neurons to FTLD-tauopathies in behavioral variant frontotemporal dementia.  Cereb Cortex  2026 Feb 09;36(2). pii:bhag011
  28. Dworak EM, Pila S, Novack MA, Hosseinian Z, Ho EH, Ece B, Karpouzian-Rogers T, Mather MA, Han YC, Bucko P  et al.  A scoping review of emotion and non-cognitive measures of decision-making ability in older adults by the ARMCADA study.  Front Public Health  2026;14:1718861. pii:1718861
  29. Hammers DB, Eloyan A, Thangarajah M, Taurone A, Gao S, Beckett L, Kirby K, Dage JL, Nudelman K, Aisen P  et al.  Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.  Alzheimers Dement  2026 Feb;22(2):e71160. pii:e71160
  30. Arrieta VA, Benotmane JK, Du R, Habashy KJ, Zhao J, Najem H, Wang S, Hou D, Katz JL, Vázquez-Cervantes GI  et al.  Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity.  Neuro Oncol  2026 Feb 01;28(2):440-453. doi:10.1093/neuonc/noaf213
  31. Castellani RJ, Bharadwaj RA, Fisher-Hubbard AO, Deep-Soboslay A, Hyde TM, Kleinman JE, Hazrati LN, Iverson GL  Hyperphosphorylated tau and amyloid-β proteinopathy in people over age 50: Findings from the Lieber Institute for Brain Development Brain Donation Repository.  J Alzheimers Dis  2026 Feb;109(4):1858-1873. doi:10.1177/13872877251411332
  32. Chiotis K, Blazhenets G, Soleimani-Meigooni DN, Aisen PS, Amuiri A, Atri A, Beckett L, Brickhouse M, Clark DG, Dage JL  et al.  Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.  medRxiv  2026 Jan 26;. pii:2026.01.25.26344738
  33. Petersen J, Gupta SV, Apple AC, Cobia D, Dokucu ME, Donnelly ED, Gradishar WJ, Mihailovic M, Reilly JL, Voss JL  et al.  Functional dysconnectivity in breast cancer patients undergoing hormone therapy.  J Clin Exp Neuropsychol  2026 Jan 21;:1-23. doi:10.1080/13803395.2026.2617353
  34. Salvi C, Luchini SA, Pestilli F, Hanekamp S, Parrish T, Beeman M, Grafman J  The white matter of Aha! moments.  BMC Psychol  2026 Jan 20;14(1):151. pii:151
  35. Chaubey K, Vázquez-Rosa E, Tripathi SJ, Shin MK, Yu Y, Dhar M, Chakraborty S, Yamakawa M, Wang X, Sridharan PS  et al.  Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brain.  Cell Rep Med  2026 Jan 20;7(1):102535. pii:102535
  36. Khan F, Petrosyan E, Liu Y, Bahrami A, Taefi E, Geula C, Lesniak MS, Chen P  Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis.  Cancer Res  2026 Jan 02;86(1):12-21. doi:10.1158/0008-5472.CAN-25-1791
  37. Kawles A, Zouridakis A, Nelson C, Keszycki R, Minogue G, Macomber A, Jamshidi P, Castellani RJ, Geula C, Gefen T  et al.  Dendritic location of dystrophic neurites in FTLD-TDP type C with annexinopathy.  Brain Pathol  2026 Jan;36(1):e70032. pii:e70032
  38. Mejia-Bautista M, Soto GS, Mitchell BI, Moravek MR, Conway K, Reyes I, Ahrendsen JT, Castellani RJ, Qi C, Jamshidi P  Disseminated BCGosis presenting as multiple intracranial lesions in an immunocompromised patient.  J Neuropathol Exp Neurol  2025 Dec 31;. pii:nlaf155
  39. Duckett D, Santana-Santos L, McCord M, Smith V, Lopes MBS, Youngblood MW, Magill ST, Chandler JP, Heimberger AB, Lukas R  et al.  Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas.  Acta Neuropathol Commun  2025 Dec 29;13(1):259. pii:259
  40. Grant RA, Runyan CE, Minogue GA, Stoolman JS, Watanabe S, Chen F, Senkow KJ, Cusick L, Schleck MJ, Nafikova R  et al.  Influenza A infection accelerates disease-associated microglia formation during physiological aging.  bioRxiv  2025 Dec 14;. pii:2025.12.11.693336
  41. Ulugut H, Younes K, Montembeault M, Bertoux M, Irish M, Kumfor F, Fumagalli GG, Samanci B, Illán-Gala I, Thompson JC  et al.  Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group.  Commun Med (Lond)  2025 Dec 12;5(1):523. pii:523
  42. Selvadurai LP, Burt AL, Daly MP, Sherman JC, Schmahmann JD  The Cerebellar Neuropsychiatric Rating Scale Version 2: Development and Validation.  Cerebellum  2025 Dec 05;24(6):185. doi:10.1007/s12311-025-01930-y
  43. Njamnshi WY, Chiotis K, Tsoy E, Blazhenets G, Maiti P, Zhang J, Allen IE, Rocha S, Shankar RP, Amuiri A  et al.  Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease.  Alzheimers Dement  2025 Dec;21(12):e71012. pii:e71012
  44. Flagan TM, Chu SA, Häkkinen S, Zhang L, McFall D, Rohrer JD, Brown JA, Lee AJ, Fernhoff K, Pasquini L  et al.  Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers.  Ann Clin Transl Neurol  2025 Dec;12(12):2575-2588. doi:10.1002/acn3.70170
  45. Iverson GL, Jamshidi P, Deep-Soboslay A, Hyde TM, Kleinman JE, Fisher-Hubbard AO, deJong JL, Shepherd CE, Hazrati LN, Castellani RJ  Chronic Traumatic Encephalopathy Neuropathologic Change in Military Veterans.  Mil Med  2025 Nov 10;. pii:usaf553
  46. Chan KCG, Dodge HH, Sano M, Au R, Craft S, Levey AI, Weintraub S, Kukull WA, Saykin AJ, Barnes LL  Comparable performance of the NACC Uniform Data Set version 3 neuropsychological test battery in assessing longitudinal cognitive change for African American and White participants.  Alzheimers Dement  2025 Nov;21(11):e70889. pii:e70889
  47. Castellani RJ, Jamshidi P, Plascencia-Villa G, Perry G  The Amyloid Cascade Hypothesis: A Conclusion in Search of Support.  Am J Pathol  2025 Nov;195(11):1988-1997. doi:10.1016/j.ajpath.2024.10.014
  48. Ho EH, Karpouzian-Rogers T, Ayturk E, Bedjeti K, Weintraub S, Gershon R  NIH Toolbox Cognition Performance in Older Adults with Normal Cognition, Mild Cognitive Impairment, and Mild Dementia of the Alzheimer's Type: Results from the ARMADA Study.  Arch Clin Neuropsychol  2025 Oct 19;40(7):1279-1287. doi:10.1093/arclin/acaf035
  49. Thomas AB, Matthews AL, Brooks O, Winquist A, Nelson LA, Arias-Fontenot R, Buchwald D, Casaletto KB, Weintraub S, Heaton RK  et al.  Psychometric properties of the NIH Toolbox Cognition Battery composites in older adults at risk for Alzheimer's disease and related dementias: A systematic review.  Alzheimers Dement  2025 Oct;21(10):e70673. pii:e70673
  50. Fischer DL, Grinberg LT, Ahrendsen JT, Beach TG, Bieniek KF, Castellani RJ, Chkheidze R, Cobos I, Cohen M, Crary JF  et al.  Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers.  Alzheimers Dement  2025 Oct;21(10):e70734. pii:e70734

Follow Mesulam Institute on Facebook